| Value | ₹3.95 Cr |
|---|
BSE filing, NSE: SHUKRAPHAR. Summary written from the filing by ALFA Finder's alert engine.
Shukra Pharmaceuticals Ltd: key numbers
- Share price
- ₹71.89
- Market cap
- ₹3,181 Cr
- Revenue (annual)
- ₹56.73 Cr
- Net profit (annual)
- ₹22.06 Cr
- P/E (TTM)
- 93.6×Sector 46.1×
- Promoter holding
- 51.15%+0.19% QoQ
- FII holding
- 0.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shukra Pharmaceuticals Ltd
All →Shukra Pharmaceuticals Board Meeting Date
Shukra Medtech Limited has scheduled a board meeting on November 3, 2026, to consider and approve its unaudited financial results for the quarter ended September 2026.
Shukra Pharmaceuticals Other Announcement
Shukra Medtech submitted a revised CA certificate to NSE for its name and symbol change application. The filing requests final exchange approval for the corporate rename.
Shukra Pharmaceuticals Other Announcement
Shukra Pharmaceuticals Limited has submitted the certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Shukra Pharmaceuticals Capital Structure Change
Shukra Pharmaceuticals allotted 17.35 lakh equity shares upon warrant conversion to promoters. The exercise raised Rs. 4.63 Crore, increasing the paid-up capital.
- Value
- ₹4.63 Cr
Shukra Pharmaceuticals Price Movement Clarification
Shukra Pharmaceuticals clarified that the recent share price movement is market-driven. The company confirmed no undisclosed, price-sensitive information exists.
Shukra Pharmaceuticals Annual General Meeting
Shukra Pharmaceuticals Ltd issued a corrigendum to its Postal Ballot notice regarding the proposed alteration of its Main Object Clause and name change.
Other fund raise announcements
All →MosChip Technologies Fund Raise of ₹112.2 Cr
MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.
- Value
- ₹112.2 Cr
Cholamandalam Investment & Finance Company Fund Raise
Cholamandalam's board approved a Qualified Institutions Placement fund raise on 28 October 2026, subject to shareholder postal ballot. The quantum, price and terms remain undetermined.
Bodhi Tree Multimedia Fund Raise
Bodhi Tree Multimedia's EOGM on October 28, 2026, sought approval for a qualified institutions placement. The filing states no issue size.
Avalon Technologies Fund Raise of ₹425 Cr
Avalon Technologies' board approved a preferential warrant issue to Zollner Elektronik AG worth about ₹425 Crore. Shareholder approval is required at an EGM on 21 November 2026.
- Value
- ₹425.0 Cr
- Execution
- Warrants exercisable within 18 months from allotment
Sealmatic India Fund Raise of ₹15.01 Cr
Sealmatic India's board approved a ₹15.01 Crore preferential issue of 3,61,620 equity shares at ₹415 to two non-promoter investors. Shareholder approval at EGM is pending.
- Value
- ₹15.01 Cr
Sky Gold and Diamonds Fund Raise of ₹1,800 Cr
Sky Gold and Diamonds' EGM on 18 November 2026 seeks approval to raise up to ₹1,800 crore via equity-linked securities. Remote e-voting closes 17 November 2026.
- Value
- ₹1,800 Cr